Effects of Testosterone Replacement Therapy on Sexual Interest, Function, and Behavior in HIV-Positive Men

    January 1997 in “ ˜The œjournal of sex research/˜The œJournal of sex research ”
    Glenn Wagner, Judith G. Rabkin, Richard Rabkin
    TLDR Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.
    In a clinical trial involving 80 HIV+ men with low CD4 cell counts and low serum testosterone levels who reported reduced sexual interest and/or dysfunction, testosterone replacement therapy was administered for 8 weeks with biweekly intramuscular injections, starting at 200 mg and increasing to 400 mg at Week 2. After the initial treatment phase, 73 men completed it, with 67 (92%) showing clear improvement as assessed by the study doctor. Despite a 9% dropout rate, significant enhancements in self-rated sexual interest, erectile functioning, and overall sexual satisfaction were reported. Increases in sexual activity, including masturbation, were noted even though many participants were sexually abstinent before treatment. The study suggests that testosterone replacement can significantly improve the quality of life and vitality by restoring sexuality in HIV+ men.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 1000+ results

    Similar Research

    5 / 1000+ results
      Lab Quality Management and Methodology

      research Lab Quality Management and Methodology

      January 2015 in “Indian Journal of Medical Biochemistry”
      Men with early balding should be checked for metabolic syndrome, as there's a link between the two.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research 2015

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.
      Dermatologic Care for Lesbian, Gay, Bisexual, and Transgender Persons

      research Dermatologic Care for Lesbian, Gay, Bisexual, and Transgender Persons

      47 citations, February 2019 in “Journal of The American Academy of Dermatology”
      LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.